Table 2 Base case results
Option | Major bleeds/100 person-year | Major TE/100 person-year | Cost/patient (CAD $) | QALY/patient | Cost/QALY | ∆ Cost CAD $ | ∆ QALY | ICUR |
|---|---|---|---|---|---|---|---|---|
Standard warfarin* dosage | 3.21 | 2.12 | 7 289 | 3.5368 | 2061 | Â | Â | Â |
Pharmacogenetic oriented warfarin dosage | 3.09 | 2.126 | 7 749 | 3.5453 | 2186 | 460 | 0.0085 | Dominated |
Dabigatran 150Â mg BID | 2.872 | 1.813 | 8 494 | 3.7897 | 2241 | 745 | 0.2444 | 4 765 |